Omega Protein, Dr. Axe, No Cow: Health And Wellness Industry News

  
Generate a summary of this article
Listen to this article
Beta

Omega Protein stockholders vote Dec. 19 on proposed acquisition by Cooke; Endexx acquires Holistic Earth Remedies to improve timing for CBD product commercialization; Dr. Axe brands protein; and more health and wellness industry news.

Arrow flying to target with radial motion blur

[Omega Protein Corp.] shareholders will vote Dec. 19 in Houston on a proposal to approve the company's decision to merge with Cooke Inc., a Canadian aquaculture firm and on a non-binding proposal to approve compensation payable to executives in connection with the merger. In a Nov. 27 release, Omega Protein and Cooke said that pending approval of stockholders and satisfaction of closing conditions, they expect the deal to close during the current quarter or the 2018 first quarter. The firms entered the agreement Oct. 5, 15 months after a hedge fund shareholder gained board seats and pushed for a sale and for the firm to leave the human nutritional space to focus on animal feed. Cooke agreed to acquire all Omega Protein outstanding shares for $22 cash, a 32.5% premium to its closing share price. (Also see "Omega Protein, Herbalife, MET-Rx: Health And Wellness Industry News" - HBW Insight, 9 October, 2017.)

Phytonutrient-based food and nutritional productsprovider Endexx Corp. acquired therapeutic topical delivery systems firm Holistic Earth Remedies LLC to integrate full-scale...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from United States

Different Name, Same Contamination, Recall Problems For US Homeopathic Nasal Spray Firm

Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.

Lauder’s Outgoing CFO Breaks Down Global Prestige Beauty, Firm’s Transition Moment

 
• By Eileen Francis

Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.

Perrigo Securities Class-Action Settlement Awards Attorneys’ Fees, Expenses Lower Than Requested

 
• By Malcolm Spicer

Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.

More from North America

US FDA Adcomm Reform Ideas: Neutral Facilitator As Chair, Public Hearing Lottery Process Tweaks

 
• By Sue Sutter

Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process. 

Kratom Industry Argues FDA Wants To Label All Products As Adverse Events Without Evidence

 
• By Malcolm Spicer

Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.

ACNU Switch And IND Exemption Final Rules Targeted For October In FDA Regulatory Goals

 
• By Malcolm Spicer

Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.